What is AIM ImmunoTech Inc.'s Market Cap?

AIM ImmunoTech Inc.'s Market Cap is $4.8M, based on as-reported figures from SEC (XBRL) filings.

What is AIM ImmunoTech Inc.'s Enterprise Value?

AIM ImmunoTech Inc.'s Enterprise Value is -$1.6M, based on as-reported figures from SEC (XBRL) filings.

What is AIM ImmunoTech Inc.'s Price / Sales?

AIM ImmunoTech Inc.'s Price / Sales is 50.1×, based on as-reported figures from SEC (XBRL) filings.

What is AIM ImmunoTech Inc.'s EV / Revenue?

AIM ImmunoTech Inc.'s EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.

What is AIM ImmunoTech Inc.'s EV / EBITDA?

AIM ImmunoTech Inc.'s EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.

What is AIM ImmunoTech Inc.'s Revenue (TTM)?

AIM ImmunoTech Inc.'s Revenue (TTM) is $95.0K, based on as-reported figures from SEC (XBRL) filings.

What is AIM ImmunoTech Inc.'s Net Income (TTM)?

AIM ImmunoTech Inc.'s Net Income (TTM) is -$14.3M, based on as-reported figures from SEC (XBRL) filings.

What is AIM ImmunoTech Inc.'s EBITDA?

AIM ImmunoTech Inc.'s EBITDA is -$11.0M, based on as-reported figures from SEC (XBRL) filings.

What is AIM ImmunoTech Inc.'s Diluted EPS (TTM)?

AIM ImmunoTech Inc.'s Diluted EPS (TTM) is -0.47, based on as-reported figures from SEC (XBRL) filings.

What is AIM ImmunoTech Inc.'s EBITDA Margin?

AIM ImmunoTech Inc.'s EBITDA Margin is -11530.5%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

AIM ImmunoTech Inc.

XASE · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001SB9J29

0.16▼ 0.00 (-2.92%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 0.16
Day's Range: 0.15 – 0.17
52-Week Range: 0.15 – 2.88
Volume: 907.8K
Avg Volume: 1.1M

Share Statistics

Shares Outstanding
Employees: 21
Exchange: XASE
Listed: 1995-11-02

Share count as of August 7, 2026

AIM ImmunoTech Inc. (AIM) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about AIM ImmunoTech Inc. (AIM)

What is AIM ImmunoTech Inc.'s Market Cap?: AIM ImmunoTech Inc.'s Market Cap is $4.8M, based on as-reported figures from SEC (XBRL) filings.
What is AIM ImmunoTech Inc.'s Enterprise Value?: AIM ImmunoTech Inc.'s Enterprise Value is -$1.6M, based on as-reported figures from SEC (XBRL) filings.
What is AIM ImmunoTech Inc.'s Price / Sales?: AIM ImmunoTech Inc.'s Price / Sales is 50.1×, based on as-reported figures from SEC (XBRL) filings.
What is AIM ImmunoTech Inc.'s EV / Revenue?: AIM ImmunoTech Inc.'s EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is AIM ImmunoTech Inc.'s EV / EBITDA?: AIM ImmunoTech Inc.'s EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is AIM ImmunoTech Inc.'s Revenue (TTM)?: AIM ImmunoTech Inc.'s Revenue (TTM) is $95.0K, based on as-reported figures from SEC (XBRL) filings.
What is AIM ImmunoTech Inc.'s Net Income (TTM)?: AIM ImmunoTech Inc.'s Net Income (TTM) is -$14.3M, based on as-reported figures from SEC (XBRL) filings.
What is AIM ImmunoTech Inc.'s EBITDA?: AIM ImmunoTech Inc.'s EBITDA is -$11.0M, based on as-reported figures from SEC (XBRL) filings.
What is AIM ImmunoTech Inc.'s Diluted EPS (TTM)?: AIM ImmunoTech Inc.'s Diluted EPS (TTM) is -0.47, based on as-reported figures from SEC (XBRL) filings.
What is AIM ImmunoTech Inc.'s EBITDA Margin?: AIM ImmunoTech Inc.'s EBITDA Margin is -11530.5%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · AIMAs-filed SEC (XBRL) data